Beliefs about vaccination and relation to COVID-19 vaccination side-effects in asthma patients.

A. Bossios (Stockholm, Sweden), A. Bacon (Plymouth, United Kingdom), K. Eger (Amsterdam, Netherlands), D. Paróczai (Szeged, Hungary), F. Schleich (Liege, Belgium), S. Hanon (Brussel, Belgium), S. Sergejeva (Tallinn, Estonia), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Aggelopoulou (Ioannina, Greece), K. Kostikas (Ioannina, Greece), E. Gaki (Ioannina, Greece), N. Rovina (Athens, Greece), Z. Csoma (Budapest, Hungary), I. Grisle (Riga, Latvia), K. Bieksiené (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), A. Ten Brinke (Leeuwarden, Netherlands), S. Hashimoto (Amsterdam, Netherlands), F. Mihaltan (Bucharest, Romania), N. Nenasheva (Moscow, Russian Federation), B. Zvezdin (Sremska Kamenica, Republic of Serbia), I. Cekerevac (Kragujevac, Republic of Serbia), S. Hromiš (Sremska Kamenica, Republic of Serbia), V. Cupurdija (Kragujevac, Republic of Serbia), Z. Lazic (Kragujevac, Republic of Serbia), R. Chaudhuri (Glasgow, United Kingdom), S. Smith (Glasgow, United Kingdom), H. Rupani (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), O. Fulton (Edinburgh, United Kingdom), B. Frankemölle (Heemskerk, Netherlands), P. Howarth (Middlesex, United Kingdom), C. Porsbjerg (Copenhagen, Denmark), E. Bel (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), M. Hyland (Plymouth, United Kingdom)

Source: International Congress 2022 – Update on clinical trials in allergy, asthma and COPD

Session: Update on clinical trials in allergy, asthma and COPD
Session type: Thematic Poster
Number: 3207

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Bossios (Stockholm, Sweden), A. Bacon (Plymouth, United Kingdom), K. Eger (Amsterdam, Netherlands), D. Paróczai (Szeged, Hungary), F. Schleich (Liege, Belgium), S. Hanon (Brussel, Belgium), S. Sergejeva (Tallinn, Estonia), E. Zervas (Athens, Greece), K. Katsoulis (Thessaloniki, Greece), A. Aggelopoulou (Ioannina, Greece), K. Kostikas (Ioannina, Greece), E. Gaki (Ioannina, Greece), N. Rovina (Athens, Greece), Z. Csoma (Budapest, Hungary), I. Grisle (Riga, Latvia), K. Bieksiené (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), A. Ten Brinke (Leeuwarden, Netherlands), S. Hashimoto (Amsterdam, Netherlands), F. Mihaltan (Bucharest, Romania), N. Nenasheva (Moscow, Russian Federation), B. Zvezdin (Sremska Kamenica, Republic of Serbia), I. Cekerevac (Kragujevac, Republic of Serbia), S. Hromiš (Sremska Kamenica, Republic of Serbia), V. Cupurdija (Kragujevac, Republic of Serbia), Z. Lazic (Kragujevac, Republic of Serbia), R. Chaudhuri (Glasgow, United Kingdom), S. Smith (Glasgow, United Kingdom), H. Rupani (Southampton, United Kingdom), H. Haitchi (Southampton, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), O. Fulton (Edinburgh, United Kingdom), B. Frankemölle (Heemskerk, Netherlands), P. Howarth (Middlesex, United Kingdom), C. Porsbjerg (Copenhagen, Denmark), E. Bel (Amsterdam, Netherlands), R. Djukanovic (Southampton, United Kingdom), M. Hyland (Plymouth, United Kingdom). Beliefs about vaccination and relation to COVID-19 vaccination side-effects in asthma patients.. 3207

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.